Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWuerzburg University Hospital

About this trial

The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment discontinuation. Although many non-pharmacological recommendations exist, it is unclear which methods are suitable for which individuals. This pilot study aims to use an AI-based, or rule-driven system to generate personalized recommendations based on patients' specific impairments and taste disorder. For the pilot study, the AI will be trained on recipes to create individualized meal plans, helping to identify foods that are likely to be better. The primary endpoint is the assessment of the nutritional intervention as helpful at the second visit within 12 weeks of inclusion.

Eligibility criteria

Qualifiers

Age ≥ 18

Suffering from one of the following tumor entities: Multiple myeloma or malignant tumor of the gastrointestinal tract

Mainly oral nutrition

Subjectively perceived tumor therapy-related taste disorder

Disqualifiers

Pregnancy

Taste disorder explained by other causes (e.g. existing before therapy or COVID disease)

Placement in an inpatient care facility

Trial design

Treatments tested in this trial

  • Gustabor server

Treatment groups

51 Participants
are divided into 1 treatment group

Sponsors and collaborators

Wuerzburg University Hospital

Lead sponsor

LMU Klinikum

Collaborator

University Hospital Regensburg

Collaborator